Cambridge Major Laboratories' US Development Headquarters is housed in a state-of-the-art 60,000 square foot GMP facility. The site has all of the capabilities required to provide API development and API manufacturing services from early pre-clinical to post-NDA commercial production. The facility has a wide range of technologies including plant scale hydrogenation and cryogenics (-90C).
General features of the US Development Facility are as follows:
The facility incorporates all of the latest technologies for HVAC and Process control. The HVAC systems are controlled by a Building Automation System (BAS) which monitors the temperature, pressures and humidity of the processing areas (labs and plant). Each processing area contains its own Air Handling Unit with once-through air.
From Discovery through commercial manufacture of active pharmaceutical ingredients – We Deliver
Learn more about the industry’s most compelling topics, brought to you by CML’s thought leaders. Our subject matter experts will focus on best practices in drug discovery ranging from early preclinical development...